That is funny. But something else is funny here. The whole Lung thing, and Northwest is not mentioned on the page as far as I can see. Maybe this trial was designed by somebody else so NWBO was caught off guard by the timing of the clinicaltrials.gov listing. Maybe NWBO has a lung trial also in the plans and reformulated a tad for that trial, and that this trial wants to use that reformulation. Seems likely they would reformulate with anything and everything they have learned in the last 10 years if starting over from phase 2 on any indication. This regardless of how well DCVax-L has been working.
One explanation for the lack of PR's, if only believed by us that can see LP's halo, is that they are being super careful not to poison the trial legal issues by saying too much. That would fit here.
News 
Market Data 
Discover 
